Fascia iliaca compartment block by O'Reilly, N. et al.
The	fascia	iliaca	compartment	block	(FICB)	was	first	described	by	Dalens	and	colleagues1	 in	1989	and	remains	a	popular	regional	anaesthetic	technique	for	surgical	procedures	involving	the	hip	 joint	and
femur.	The	FICB	may	be	thought	of	as	an	anterior	approach	to	the	lumbar	plexus	where	local	anaesthetic	(LA)	is	injected	proximally	beneath	the	fascia	iliaca,	with	the	aim	of	blocking	the	femoral	nerve	(FN),	obturator
nerve	(ON),	and	lateral	cutaneous	nerve	of	thigh	(LCNT)	simultaneously.	Unlike	the	FN	block,	the	needle	is	not	directed	to	lie	adjacent	to	the	FN,	thus	reducing	the	risk	of	neuropraxia.	In	clinical	practice,	the	FICB
provides	a	safe	and	relatively	simple	alternative	to	femoral	and	lumbar	plexus	blocks.
Anatomy
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Key	points
• The	hip	is	supplied	by	nerves	arising	from	both	lumbar	and	sacral	plexuses.
• Fascia	iliaca	compartment	block	(FICB)	may	be	performed	using	a	landmark	or	ultrasound-guided	approach.
• FICB	is	recommended	for	preoperative	analgesia	in	patients	with	hip	fracture.
• FICB	is	opioid-sparing	but	does	not	provide	complete	analgesia	for	hip	surgery.
• As	with	any	regional	anaesthetic	block,	appropriate	monitoring	is	needed	to	ensure	safety.
Learning	objectives
By	reading	this	article,	you	should	be	able	to:
• Describe	and	identify	the	pertinent	anatomy	for	performing	FICB.
• Explain	the	anatomical	and	ultrasound	guided	approaches	to	the	FICB.
• Discuss	which	patient	groups	would	potentially	benefit	from	a	FICB.
• Define	the	safe	performance	of	a	FICB	and	the	recommended	requirements	for	monitoring.
Hip	joint
The	hip	joint	consists	of	a	ball	(femoral	head)	and	socket	(acetabulum)	with	the	femoral	head,	neck,	and	greater	and	lesser	trochanters	comprising	the	proximal	end	of	the	femur.	The	psoas	major	muscle	originates	from	the
vertebral	bodies	of	T12–L4	and	costal	processes	of	the	L1–L5	vertebrae	and	merges	with	the	iliacus	muscle	(which	originates	from	the	inner	surface	of	the	iliac	bone)	before	inserting	into	the	lesser	trochanter.	The	greater	trochanter
provides	the	insertion	for	gluteus	medius	and	gluteus	minimus	muscles.2
Innervation	of	the	hip	joint
The	sensory	nerve	supply	to	the	hip	joint	includes	the	FN,	ON,	articular	branches	of	the	sciatic	nerve,	nerves	supplying	quadratis	femoris,	and	superior	gluteal	nerve	(Fig.	1).3	Sensory	innervation	of	the	skin	on	the	lateral	thigh	is	supplied	by	the
LCNT	and	by	the	lateral	cutaneous	branch	of	the	subcostal	nerve.	Sensation	to	the	upper	anterior	portion	of	the	thigh	is	supplied	by	the	ilioinguinal	and	genitofemoral	nerves	(Fig.	2).3	The	FN,	ON,	and	LCTN	arise	from	the	lumbar	plexus,	whereas	the
sciatic	nerve,	nerve	supplying	quadratis	femoris,	and	superior	gluteal	nerve	arise	from	the	sacral	plexus.	Therefore,	anaesthesia	of	the	hip	joint	cannot	be	fully	achieved	with	a	FICB	alone.
Fascia	iliaca,	and	its	relationship	to	femoral,	lateral	cutaneous,	and	obturator	nerves
Fig	1	Innervation	of	the	hip.	Anterior	portion	of	the	joint	capsule:	(1)	branch	of	the	femoral	nerve	(L1–L4)	along	the	iliopsoas	muscle.	Anteromedial	portion:	(2)	a	branch	of	the	obturator	nerve	(L1–L4).	Posterior	portion:	(3)	branches	of	the	sciatic	nerve.
alt-text:	Fig	1
Fig	2	Cutaneous	innervation	of	the	hip	and	relation	to	surgical	incision	sites	for	(1)	THR	posterior	approach,	(2)	THR	lateral	approach,	(3)	THR	anterior	approach,	(4)	dynamic	hip	screw	incision.	Note	that	the	posterior	incision	extends	beyond	the	territory	of	the	lateral	cutaneous
nerve	of	the	thigh	to	the	subcostal	territory	and	may	also	involve	the	lateral	cutaneous	branch	of	the	iliohypogastric	nerve	(origin	L1)	not	shown	here.	THR,	total	hip	replacement.
alt-text:	Fig	2
The	fascia	iliaca	compartment	is	a	potential	space	lying	between	the	fascia	ilaca	anteriorly	and	the	iliacus	and	psoas	muscles	(iliopsoas)	posteriorly.	The	fascia	iliaca	attaches	to	the	iliac	crest	laterally	and	to	the	fascia	overlying
the	psoas	muscle	medially.	It	lies	posteriorly	to	the	external	iliac	vessels	and	anteriorly	to	the	nerves	of	the	lumbar	plexus.	More	distally,	the	fascia	iliaca	invests	the	FN	and	passes	posterior	to	the	femoral	artery	and	vein	which	lie
within	the	lacuna	vasorum.	The	FN	arises	from	the	second	to	fourth	lumbar	nerve	roots	and	descends	through	the	fibres	of	psoas	major	before	passing	distally	between	the	psoas	and	iliacus	muscles.	It	then	exits	the	pelvis	to	lie
anterior	to	iliopsoas	and	lateral	to	the	femoral	vessels.	The	LCNT	is	a	purely	sensory	nerve	which	arises	from	the	second	and	third	lumbar	nerve	roots	and	passes	deep	to	the	fascia	iliaca	before	leaving	the	fascial	plane	around	the	level
of	the	inguinal	ligament.	The	ON	arises	from	the	second	to	fourth	lumbar	roots,	is	predominantly	a	motor	nerve,	and	inconsistently	innervates	a	proportion	of	the	skin	of	the	medial	thigh.4	After	penetrating	the	fascia	and	leaving	the
fascia	iliaca	compartment,	the	ON	passes	posterior	to	the	common	iliac	artery	before	reaching	the	obturator	foramen.	All	of	these	nerves	lie	within	the	fascia	iliaca	compartment	at	the	proximal	end	of	their	anatomical	course,	and
therefore	placement	of	LA	beneath	the	fascia	iliaca	should,	in	theory,	result	in	anaesthesia	of	FN,	ON,	and	LCNT.	The	genitofemoral	nerve	runs	on	the	anterior	aspect	of	the	psoas	muscle	posterior	to	the	fascia	iliaca	and	therefore,	the
FICB	may	also	result	in	anaesthesia	of	the	genitofemoral	nerve	(Fig.	3).5
Fascia	iliaca	compartment	block
Indications,	contraindications,	and	complications
Indications	for	FICB	include	pre-,	peri-,	and	postoperative	analgesia	after	fractured	neck	of	femur	(NOF).	Additional	indications	include	hip	and	knee	surgery,	above	knee	amputation,	and	application	of	plaster	cast	to	femoral
fracture	in	paediatric	patients,	although	data	to	support	these	indications	are	limited.	Contraindications	include	previous	femoral	bypass	surgery,	patient	refusal,	allergy	to	LA,	and	infection	at	the	block	site.	Relative	contraindications
include	patients	with	coagulopathy,	peripheral	neuropathy,	or	neurological	conditions.	Complications	 include:	block	 failure,	haematoma,	neuropraxia,	 local	anaesthetic	systemic	 toxicity	 (LAST),	quadriceps	weakness,	perforation	of
peritoneal	cavity	contents,	and	bladder	puncture.
Block	technique
Traditionally,	 the	 FICB	was	 undertaken	 using	 a	 simple,	 landmark-guided	 approach.	 Ultrasound	 guidance	 is	 now	 commonplace,	 however.	 Ultrasound	 has	 also	 facilitated	 the	 development	 of	more	 proximal,	 suprainguinal
approaches	to	the	FICB.	This	is	because	successful	blockade	of	LCNT	and	ON	relies	on	proximal	spread	of	LA	as	both	of	these	nerves	generally	lie	superior	to	the	fascia	iliaca	distal	to	the	inguinal	ligament	(Fig.	3).
Landmark	technique
Anatomical	landmarks	are	the	inguinal	ligament,	anterior	superior	iliac	spine	(ASIS),	and	pubic	tubercle.	The	patient	is	positioned	supine,	and	a	line	connecting	the	ASIS	and	the	pubic	tubercle	is	divided	into	thirds.	The	injection	is	performed	at	a
point	1	cm	caudad	to	the	junction	of	the	lateral	third	and	medial	two	thirds.	The	ipsilateral	femoral	pulse	is	palpated	approximately	1.5	cm	medial	to	the	point	of	injection.	A	blunt,	short-bevel	needle	is	inserted	perpendicular	to	the	skin	and	the	needle	angle
adjusted	to	approximately	60°	and	directed	cranially.	A	‘give’	or	‘pop’	may	be	felt	as	the	needle	passes	through	fascia	lata,	and	a	second	‘give’	as	it	passes	through	the	fascia	iliaca.	The	needle	angle	is	adjusted	to	approximately	30°	and	advanced	a	further
1–2	mm.	LA	should	be	injected	without	experiencing	resistance.	If	resistance	occurs,	the	needle	should	be	withdrawn	slightly	and	injection	reattempted	after	further	aspiration.
Ultrasound	guided	infrainguinal	approach
In	the	supine	position	as	before,	a	high	frequency	(6–14	MHz)	linear	probe	is	placed	transversely	to	identify	the	femoral	artery	at	the	inguinal	crease.	The	iliopsoas	muscle	with	the	overlying	fascia	iliaca	is	identified	and	the	hyperechoic	FN	is
Fig	3	Schematic	diagram	of	fascia	iliaca	and	related	structures.
alt-text:	Fig	3
typically	seen	lying	between	the	iliopsoas	and	fascia	iliaca	at	a	depth	of	2–4	cm,	lateral	to	the	femoral	artery	(Fig.	4).	The	fascia	lata	may	also	be	identified	above	the	fascia	iliaca,	although	this	is	neither	always	reliably	seen	nor	essential	to	the	performance
of	the	block.	The	probe	may	be	tilted	cranially	and	caudally	until	optimal	images	of	the	FN	and	fascia	iliaca	are	obtained.	The	triangular	shaped	sartorius	muscle	and	the	ASIS	are	identified	on	moving	the	probe	laterally.	After	skin	disinfection	and	LA
infiltration,	a	50–100	mm	blunt	ended	needle	is	inserted	using	an	in-plane	technique	with	the	aim	of	placing	the	needle	tip	beneath	the	fascia	iliaca	around	the	lateral	third	of	a	line	between	the	ASIS	and	pubic	tubercle.	Aspiration	is	performed	before
injection	of	1–2	ml	LA.	Correct	needle	placement	is	confirmed	by	separation	of	the	fascia	iliaca	from	the	iliopsoas	muscle	with	LA	spreading	towards	the	FN	medially	and	the	iliac	crest	laterally.6	Volumes	of	30–40ml,	ensuring	compliance	with	safe	dose
limits	for	the	LA,	are	routinely	used	to	ensure	optimal	spread.
Ultrasound	guided	suprainguinal	approach
The	ultrasound-guided	(USG)	longitudinal	suprainguinal	approach	to	the	FICB	was	first	described	in	a	cadaver	study	by	Hebbard	in	2011.7	In	this	technique,	the	patient	is	positioned	supine	and	a	high-frequency	linear	probe	(6–14	MHz)	is	placed
sagitally	to	obtain	an	image	of	the	ilium	and	iliacus	muscle.	The	femoral	artery	is	seen	by	moving	the	probe	inferiorly	and	medially	along	the	inguinal	ligament.	The	probe	is	then	moved	laterally	and	superiorly	along	the	inguinal	ligament	towards	the	ASIS
to	lie	laterally	to	the	FN.	The	deep	circumflex	artery	is	identified	superficial	to	the	fascia	iliaca	and	1–2	cm	cephalad	to	the	inguinal	ligament,	and	this	provides	a	further	landmark	for	needle	placement.	The	needle	is	inserted	2–4	cm	caudad	to	the	inguinal
ligament	aiming	ultimately	to	be	beneath	the	fascia	iliaca	cephalad	to	the	inguinal	ligament.	LA	spread	should	be	seen	between	the	fascia	iliaca	and	iliacus	muscle	and	into	the	iliac	fossa.	The	authors	concluded	that	this	technique	may	provide	a	more
targeted	approach	to	the	FICB,	reducing	LA	volume	requirements	and	facilitating	FICB	catheter	placement.	Spread	of	LA	to	the	ON	was	not	reported	in	this	study.
The	suprainguinal	approach	to	the	FICB	has	also	been	described	using	a	more	proximal	needle	insertion	point.8	With	the	patient	supine,	a	linear	high	frequency	probe	(6–14	MHz)	is	placed	in	the	sagittal	plane	to	obtain	an	image	of	the	ASIS.	The
probe	is	moved	medially	and	the	fascia	iliaca	and	sartorius,	iliopsoas,	and	internal	oblique	muscles	are	identified.	After	identifying	the	‘bowtie	sign’	formed	by	the	muscle	fasciae,	a	100	mm	needle	is	introduced	1	cm	cephalad	to	the	inguinal	ligament.	Using
an	in-plane	approach,	the	needle	tip	is	positioned	beneath	the	fascia	iliaca,	and	hydro-dissection	is	used	to	separate	the	fascia	iliaca	from	the	iliacus	muscle.	The	needle	is	further	advanced	in	this	space	in	a	cranial	and	slightly	dorsal	direction.	The	deep
circumflex	artery	lies	superficial	to	the	fascia	iliaca	and	upward	movement	of	this	artery	upon	injection	can	be	used	as	a	marker	of	fascia	iliaca	penetration.	An	injection	is	considered	successful	if	spread	of	LA	is	observed	cranial	to	the	point	where	the	iliac
muscle	passes	under	the	abdominal	muscles	(see	Fig.	5).	If	adequate	spread	is	not	observed,	the	needle	should	be	repositioned.	A	recent	cadaveric	study	found	that	a	volume	of	40	ml	was	required	to	reliably	block	all	three	nerves	using	this	approach.6
Fig	4	Sonoanatomy	of	infrainguinal	approach	to	fascia	iliaca	compartment	block.	FA,	femoral	artery;	FN,	femoral	nerve;	FI,	fascia	iliaca;	IM,	iliacus	muscle;	IPM,	iliopsoas	muscle.
alt-text:	Fig	4
Single	shot	techniques	and	catheters
The	FICB	 is	a	 fascial	plane	block	and	therefore	success	depends	upon	adequate	spread	of	LA	towards	 the	 targeted	nerves.	For	 the	 landmark	and	USG	 infrainguinal	approach	30–40	ml	of	LA	 is	 recommended,	and	 for	 the	USG	suprainguinal
approach	at	least	40	ml	of	LA	is	required	to	consistently	block	the	FN,	ON,	and	LFCN.9	Long-acting	LA	such	as	ropivacaine	and	levobupivacaine	are	commonly	used	to	provide	extended	analgesia.	Safe	dosing	limits	clearly	must	not	be	exceeded	to	avoid
systemic	toxicity.	Reassuringly,	in	a	study	investigating	longitudinal	suprainguinal	FICB	in	patients	undergoing	total	hip	arthroplasty,	plasma	ropivacaine	levels	after	40	ml	ropivacaine	0.5%	were	within	the	maximal	tolerated	plasma	concentrations	(as
described	by	Knudsen	and	colleagues9)	 in	all	patients.	Time	 to	maximum	concentration	was	45	min,	 indicating	 that	patients	 should	be	monitored	and	observed	 for	at	 least	45–60	min	after	block	performance.8	Care	should	also	be	 taken	 to	minimise
intramuscular	injections	to	avoid	LA-associated	myotoxicity.
The	duration	of	analgesia	may	be	extended	using	a	catheter	technique.	However,	data	are	surprisingly	scarce.	It	is	also	unclear	whether	a	fixed	infusion	rate	or	intermittent	bolus	is	superior	although	an	intermittent	bolus	regimen	with	injection	of
sufficiently	large	amounts	of	LA	intuitively	may	lead	to	better	spread	than	a	fixed	infusion.
Evidence
Initial	studies	comparing	a	landmark	technique	FICB	with	a	‘3	in	1’	block	in	both	children	and	adults	resulted	in	higher	success	rates	for	FICB.	However,	LA	spread	was	variable	and	inconsistent	and	neither	block	achieved
sensory	anaesthesia	in	all	three	nerves	in	any	more	than	38%	of	patients.1,10	The	advent	of	USG	renewed	interest	in	the	FICB	prompting	studies	comparing	landmark	and	USG	techniques.	In	a	study	comparing	USG	infrainguinal	and
landmark	techniques,	sensory	anaesthesia	in	all	parts	of	the	thigh	was	significantly	higher	in	the	USG	infrainguinal	group.11	The	incidence	of	femoral	and	obturator	motor	block	was	also	higher	in	the	USG	infrainguinal	group.	To
confirm	ON	motor	block,	a	reduction	of	adductor	strength	of	at	least	75%	is	necessary	to	exclude	the	effect	of	the	FN,	as	an	FN	block	will	also	reduce	adductor	strength	because	of	its	innervation	of	the	pectineus	muscle.8	In	a	study
using	MRI	 to	 evaluate	 the	 spread	 of	 LA	 after	 USG	 infrainguinal	 FICB,	 the	 FN	 and	 LFCN	were	 consistently	 blocked	 but	 there	was	 no	 evidence	 of	 spread	medially	 or	 cranially	 to	 reliably	 block	 the	 ON.12	 The	USG	 longitudinal
suprainguinal	approach	to	the	FICB	theoretically	improves	block	success	rates	as	the	LA	is	injected	more	cranially	allowing	more	consistent	block	of	the	three	targeted	nerves	(FN,	LFCN,	and	ON).	Success	rates	of	ON	blockade	and
blockade	of	all	three	nerves	were	86%	and	67%,	respectively,	in	an	RCT	comparing	USG	suprainguinal	FICB	with	placebo	in	patients	undergoing	total	hip	replacement	(THR).8	Indeed,	a	recent	cadaver	study	demonstrated	that	the	FN,
LFCN,	and	ON	could	be	reliably	blocked	using	an	USG	suprainguinal	FICB,	but	only	if	a	volume	of	40	ml	was	injected.6	Further	research	comparing	suprainguinal	and	infrainguinal	techniques	is	necessary	to	confirm	these	findings.
Fig	5	Ultrasound	guided	suprainguinal	approach	to	the	fascia	iliaca	compartment	block.	(A)	Identification	of	relevant	anatomy.	*,	‘bowtie	sign’;	yellow	arrows,	fascia	iliaca;	ASIS,	anterior	superior	iliac	spine;	IM,	iliacus	muscle;	IOM,	internal	oblique	muscle;	SM,	sartorius	muscle.	(B)
Needle	placement	under	fascia	iliaca	using	an	in-plane	approach.	Blue	arrow,	needle	trajectory.	(C)	Injection	of	local	anaesthetic	under	fascia	iliaca.	**,	deep	circumflex	artery	seen	superficial	to	fascia	iliaca;	blue	arrow,	needle	trajectory;	LA,	local	anaesthetic	beneath	the	fascia	iliaca.
(D)	Successful	placement	of	LA	with	cranial	spread	under	fascia	iliaca.
alt-text:	Fig	5
An	alternative	but	more	technically	challenging	and	time-consuming	approach	is	to	block	all	three	nerves	individually	using	US.	Articular	branches	of	FN	and	ON	may,	however,	be	missed	by	blocking	these	nerves	too	distally.	A
recently	described	technique	targeting	the	articular	branches	of	FN	and	the	accessory	branches	of	ON	(the	PEricapsular	Nerve	Group	‘PENG’	block)	has	shown	some	promise	in	a	small	case	series	of	patients	undergoing	hip	surgery
although	further	studies	comparing	this	with	FICB	are	required.13
Fractured	NOF
FICB	is	recommended	by	national	guidelines	for	the	provision	of	analgesia	in	patients	admitted	with	fractured	NOF.14,15	Conventional	analgesics	such	as	non-steroidal	anti-inflammatory	agents	and	opioids	are	associated	with	a
wide	range	of	adverse	effects	in	this	patient	group,	and	the	use	of	FICB	can	provide	effective	pain	relief	whilst	minimising	systemic	adverse	effects.	A	Cochrane	review	found	that	the	performance	of	peripheral	nerve	block	before,
during,	or	after	operation	in	patients	suffering	fractured	NOF	reduced	both	pain	at	30	min	and	opioid	consumption	compared	with	systemic	analgesia.16	Eight	of	the	reported	studies	examined	FICB	specifically	(six	preoperative,	one
postoperative,	and	one	both	pre-	and	postoperative	analgesia)	with	all	studies	demonstrating	superior	pain	control	compared	with	systemic	analgesia.16	A	 further	systematic	review	and	meta-analysis	 found	preoperative	FIB	to	be
superior	to	opioids	for:	pain	control	on	movement,	preoperative	analgesic	consumption,	time	to	first	analgesic	request,	and	time	to	perform	spinal.17	Although	three	studies	showed	a	protective	effect	of	FICB	for	delirium,	these	data
were	not	suitable	for	meta-analysis,	and	further	evidence	is	required	to	confirm	these	findings.17	Performing	the	FICB	before	operation	has	the	added	advantage	of	providing	analgesia	for	positioning	and	shortening	time	to	perform
spinal	anaesthesia.17	The	authors	concluded	that	FICB	is	‘an	effective	and	relatively	safe	supplement’	in	the	preoperative	analgesia	of	hip	fracture	patients.17	FN	block	may	also	be	effective	in	this	context	given	that	blockade	of	the
LCNT	is	not	required	for	preoperative	analgesia.
Total	hip	arthroplasty
Evidence	for	the	use	of	FICB	in	THR	remains	mixed.	One	small	study	compared	a	modified	landmark	FICB	technique	with	placebo	and	demonstrated	reduced	morphine	consumption.18	A	further	small,	single-centre	study	failed
to	demonstrate	any	reduction	in	pain	intensity	or	opioid	consumption	at	1	and	24	h	when	comparing	USG	infrainguinal	FICB	with	placebo	in	patients	with	uncontrolled	pain	after	operation.	In	this	study,	the	ON	was	blocked	in	only	25%
of	patients	and	blockade	of	all	three	nerves	was	achieved	in	only	two	of	16	patients.19	More	recently,	an	infrainguinal	FICB	was	found	to	be	inferior	to	spinal	morphine	for	analgesia	in	the	first	24	h	after	THR.20	In	contrast,	an	RCT
using	an	suprainguinal	approach	demonstrated	a	45%	reduction	of	morphine	consumption	at	48	h	after	THR	when	compared	with	no	block.6	In	this	study,	ON	blockade	was	achieved	in	86%	and	all	three	nerves	were	blocked	in	67%	of
patients.6	Negative	studies	are	perhaps	unsurprising	when	the	innervation	from	the	sacral	plexus	and	the	limitations	of	the	more	distal	approaches	to	the	FICB	are	considered.	In	addition,	part	of	the	surgical	incision	may	lies	outwith
the	territory	of	LCNT	dependent	on	which	surgical	approach	is	used	(Fig.	3).	Regardless	of	which	approach	is	used,	the	ON	is	most	frequently	missed	with	the	FN	most	reliably	blocked.	Further	work	is	required	to	establish	whether
patients	undergoing	elective	hip	surgery	benefit	from	FICB.
Provision	of	a	fascia	iliaca	block	service
Although	FICB	in	the	emergency	department	is	becoming	a	standard	of	care,14,15	FICB	remains	underutilised	in	the	UK.	Lack	of	trained	staff	and	equipment,	procedural	time,	and	a	disbelief	in	the	efficacy	of	the	technique	are
the	most	frequent	reasons	why	FICB	is	not	more	widely	adopted.	To	overcome	these	obstacles,	many	units	have	opted	to	train	non-medical	practitioners	to	perform	the	procedure.	Regional	Anaesthesia	United	Kingdom	(RA-UK)	and	the
Association	of	Anaesthetists	of	Great	Britain	and	Ireland	(AAGBI)	 issued	a	 joint	statement	 in	2013	classifying	FICB	as	a	 ‘local	anaesthetic’	 technique	rather	 than	a	peripheral	nerve	block	because	 the	needle	 trajectory	should	not
directly	impinge	on	nerves	or	blood	vessels.21	Non-medical	healthcare	professionals	who	have	received	‘appropriate	training	and	are	following	agreed	clinical	governance	procedures’	may	perform	FICB	under	the	supervision	of	the
associated	department	of	anaesthesia.21	This	may	include	the	pre-hospital	setting.22	This	advice	was	issued	before	the	widespread	use	of	USG,	and	although	it	technically	did	not	refer	to	the	landmark-	or	US-guided	technique	this
advice	certainly	does	not	apply	to	the	US-guided	suprainguinal	approach,	which	is	closer	to	intraperitoneal	structures	and	is	technically	more	challenging	because	of	the	lack	of	vascular	and	neural	landmarks.	The	requirements	of
‘appropriate	training’	are	highlighted	in	Table	1.	Robust	audit	of	outcomes	and	adverse	events	is	recommended.18
Table	1	Training	requirements	for	performance	of	FICB.	FICB,	fascia	iliaca	compartment	block;	LA,	local	anaesthetics;	LAST,	local	anaesthetic	systemic	toxicity;	USG,	ultrasound	guided.
alt-text:	Table	1
• Knowledge	of	relevant	anatomy,	landmarks,	and	sonoanatomy
• Knowledge	of	ultrasound	physics,	knobology	for	USG	technique
• Knowledge	of	indications	and	contraindications	for	FICB
• Knowledge	of	LA	pharmacology
• Knowledge	of	signs	and	symptoms	of	LAST
• Knowledge	of	treatment	of	LAST
• Development	of	technical	skills	for	both	USG	and	landmark	techniques
Although	adverse	events	are	rare,	vigilant	practice	 is	essential	 if	 these	are	 to	be	minimised.	The	Royal	College	of	Emergency	Medicine	 (RCEM)	recently	clarified	 its	statement	about	a	death	occurring	after	a	patient	had
received	a	FICB	for	fractured	NOF.	The	patient	developed	unrecognised	respiratory	depression,	which	was	likely	to	be	related	to	previous	treatment	with	opioids	and	the	subsequent	removal	of	the	painful	stimulus	by	the	FICB.	The
RCEM	has	since	emphasised	the	importance	of	an	adequate	period	of	monitoring	after	FICB.23
Conclusion
FICB	is	a	safe	and	simple	means	of	providing	analgesia	for	procedures	involving	the	hip	joint	and	femur.	The	USG	suprainguinal	approach	appears	to	be	most	effective	at	achieving	successful	block	of	all	three	nerves,	although
technically	it	may	be	more	challenging	to	perform.	FICB	is	particularly	valuable	in	patients	admitted	with	hip	fracture	resulting	in	opioid	sparing	and	improved	dynamic	analgesia.	The	role	of	FICB	in	elective	hip	surgery	requires
further	clarification.
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